United States securities and exchange commission logo

                          November 13, 2020

       Tara Condon
       Vice President, Head of Legal Affairs
       BridgeBio Pharma, Inc.
       421 Kipling Street
       Palo Alto, CA 94301

                                                        Re: BridgeBio Pharma,
Statement on Form S-4
                                                            Filed November 6,
                                                            File No. 333-249944

       Dear Ms. Condon:

              This is to advise you that we have not reviewed and will not
review your registration

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Margaret
Schwartz at 202-551-7153 with any questions.


                          Division of Corporation Finance

                          Office of Life Sciences
       cc:                                              Thomas Greenberg, Esq.